{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Alzheimer%27s+Disease%3B+Dementia&page=2", "query": { "condition": "Alzheimer's Disease; Dementia", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Alzheimer%27s+Disease%3B+Dementia&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-07-24T09:46:00.729Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05462106", "title": "A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Amyloid Plaque", "Beta-Amyloid", "DSAD", "Prodromal Alzheimer's Disease", "Alzheimer's Disease" ], "interventions": [ { "name": "Placebo (Study Part 1a)", "type": "BIOLOGICAL" }, { "name": "ACI-24.060 at Dose A in Study Part 1a", "type": "BIOLOGICAL" }, { "name": "ACI-24.060 at Dose B in Study Part 1a", "type": "BIOLOGICAL" }, { "name": "ACI-24.060 at Dose C in Study Part 1a", "type": "BIOLOGICAL" }, { "name": "ACI-24.060 with an additional adjuvant at Dose D in Study Part 1b", "type": "BIOLOGICAL" }, { "name": "Placebo (Study Part 2)", "type": "BIOLOGICAL" }, { "name": "ACI-24.060 at Dose A in Study Part 2", "type": "BIOLOGICAL" }, { "name": "ACI-24.060 at Dose B in Study Part 2", "type": "BIOLOGICAL" }, { "name": "ACI-24.060 at Dose C in Study Part 2", "type": "BIOLOGICAL" }, { "name": "Placebo (Study Part 1b)", "type": "BIOLOGICAL" }, { "name": "ACI-24.060 with an additional adjuvant at Dose E in Study Part 1b", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "AC Immune SA", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "35 Years to 85 Years" }, "enrollment_count": 304, "start_date": "2022-06-21", "completion_date": "2029-04", "has_results": false, "last_update_posted_date": "2026-07-10", "last_synced_at": "2026-07-24T09:46:00.729Z", "location_count": 13, "location_summary": "Phoenix, Arizona • Lady Lake, Florida • Orlando, Florida + 9 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Lady Lake", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "The Villages", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05462106" }, { "nct_id": "NCT01463384", "title": "Minocycline in Patients With Alzheimer's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Mild Cognitive Impairment", "Alzheimer's Disease" ], "interventions": [ { "name": "Minocycline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Huntington Medical Research Institutes", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "55 Years to 90 Years" }, "enrollment_count": 13, "start_date": "2011-09", "completion_date": "2012-10", "has_results": true, "last_update_posted_date": "2014-09-25", "last_synced_at": "2026-07-24T09:46:00.729Z", "location_count": 1, "location_summary": "Pasadena, California", "locations": [ { "city": "Pasadena", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01463384" }, { "nct_id": "NCT03639987", "title": "A Study of Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnormalities", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cognitive Dysfunction", "Alzheimer's Disease" ], "interventions": [ { "name": "Aducanumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biogen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "50 Years to 85 Years" }, "enrollment_count": 52, "start_date": "2018-12-20", "completion_date": "2019-07-30", "has_results": true, "last_update_posted_date": "2021-09-16", "last_synced_at": "2026-07-24T09:46:00.729Z", "location_count": 22, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Fullerton, California + 18 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Fullerton", "state": "California" }, { "city": "Oxnard", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03639987" }, { "nct_id": "NCT00083421", "title": "Effects of ONO-2506PO in Patients With Alzheimer's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "ONO-2506PO", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ono Pharma USA Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "50 Years to 90 Years" }, "enrollment_count": 647, "start_date": "2004-06", "completion_date": "2007-07", "has_results": false, "last_update_posted_date": "2012-06-13", "last_synced_at": "2026-07-24T09:46:00.729Z", "location_count": 79, "location_summary": "Birmingham, Alabama • Mesa, Arizona • Phoenix, Arizona + 64 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00083421" }, { "nct_id": "NCT04308304", "title": "MK-1942/Donepezil Interactions in Participants With Alzheimer's Disease (MK-1942-005)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "MK-1942", "type": "DRUG" }, { "name": "Donepezil", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "50 Years to 85 Years" }, "enrollment_count": 27, "start_date": "2021-02-16", "completion_date": "2022-05-18", "has_results": true, "last_update_posted_date": "2024-08-15", "last_synced_at": "2026-07-24T09:46:00.729Z", "location_count": 4, "location_summary": "Rogers, Arkansas • Hallandale, Florida • Decatur, Georgia + 1 more", "locations": [ { "city": "Rogers", "state": "Arkansas" }, { "city": "Hallandale", "state": "Florida" }, { "city": "Decatur", "state": "Georgia" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT04308304" }, { "nct_id": "NCT03840928", "title": "PatientSpot Formerly Known as ArthritisPower", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Rheumatoid Arthritis", "Ankylosing Spondylitis", "Fibromyalgia", "Gout", "Crohn Disease", "Juvenile Idiopathic Arthritis", "Lupus Erythematosus", "Myositis", "Osteoarthritis", "Osteoporosis", "Psoriasis", "Psoriatic Arthritis", "Scleroderma", "Dermatomyositis", "Inflammatory Bowel Diseases", "Polymyositis", "Axial Spondyloarthritis", "Diffuse Idiopathic Skeletal Hyperostosis", "Polymyalgia Rheumatica", "Giant Cell Arteritis", "Temporal Arteritis", "Wegener", "Relapsing Polychondritis", "Undifferentiated Connective Tissue Disease", "Spinal Cord Injuries", "Alzheimer Disease", "Amyotrophic Lateral Sclerosis", "Ataxia", "Bell Palsy", "Brain Tumor", "Cerebral Aneurysm", "Epilepsy", "Guillain-Barre Syndrome", "Headache", "Head Injury", "Hydrocephalus", "Lumbar Disc Disease", "Meningitis", "Multiple Sclerosis", "Muscular Dystrophy", "Neurocutaneous Syndromes", "Parkinson Disease", "Stroke", "Cluster Headache", "Tension-Type Headache", "Chronic Obstructive Pulmonary Disease", "Asthma", "Lung Cancer", "Cystic Fibrosis", "Sleep Apnea", "Eczema", "Alopecia", "Chronic Inflammation", "Unstable Angina", "Heart Attack", "Heart Failure", "Arrythmia", "Valve Heart Disease", "High Blood Pressure", "Congenital Heart Disease", "Peripheral Arterial Disease", "Diabetes", "Chronic Liver Disease", "Obesity" ], "interventions": [], "intervention_types": [], "sponsor": "Global Healthy Living Foundation", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 40000, "start_date": "2015-04-01", "completion_date": "2025-03-01", "has_results": false, "last_update_posted_date": "2023-12-13", "last_synced_at": "2026-07-24T09:46:00.729Z", "location_count": 1, "location_summary": "Upper Nyack, New York", "locations": [ { "city": "Upper Nyack", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03840928" }, { "nct_id": "NCT01028209", "title": "Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Alzheimer Disease", "Parkinson Disease", "Multiple Sclerosis" ], "interventions": [ { "name": "[18F] PBR06", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Institute for Neurodegenerative Disorders", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 12, "start_date": "2009-11", "completion_date": "2010-09-22", "has_results": false, "last_update_posted_date": "2019-04-03", "last_synced_at": "2026-07-24T09:46:00.729Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT01028209" }, { "nct_id": "NCT03860857", "title": "Biomarker Exploration in Aging, Cognition and Neurodegeneration", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Alzheimer Disease", "Cognitive Impairment", "Cognitive Decline" ], "interventions": [ { "name": "Amyloid PET scan", "type": "RADIATION" }, { "name": "Tau PET scan using MK-6240", "type": "DRUG" }, { "name": "Neurocognitive testing", "type": "BEHAVIORAL" }, { "name": "MRI", "type": "OTHER" } ], "intervention_types": [ "RADIATION", "DRUG", "BEHAVIORAL", "OTHER" ], "sponsor": "University of California, Irvine", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 300, "start_date": "2018-05-01", "completion_date": "2027-12-22", "has_results": false, "last_update_posted_date": "2026-01-23", "last_synced_at": "2026-07-24T09:46:00.729Z", "location_count": 1, "location_summary": "Irvine, California", "locations": [ { "city": "Irvine", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03860857" }, { "nct_id": "NCT06021704", "title": "The Care for America's Aging Study", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cognitive Impairment", "Dementia With Behavioral Disturbance", "Dementia", "Alzheimer Disease" ], "interventions": [ { "name": "Enhanced home health aide training in dementia and dementia-related behaviors", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 120, "start_date": "2026-10-01", "completion_date": "2028-12-31", "has_results": false, "last_update_posted_date": "2026-07-06", "last_synced_at": "2026-07-24T09:46:00.729Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06021704" }, { "nct_id": "NCT03384043", "title": "Comparing Smartphone Technology and a Memory Strategy on Improving Prospective Memory in Alzheimer's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Alzheimer Disease", "Cognitive Impairment, Mild", "Dementia, Mild" ], "interventions": [ { "name": "Smartphone Personal Assistant", "type": "BEHAVIORAL" }, { "name": "Implementation Intention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Baylor University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 52, "start_date": "2018-01-08", "completion_date": "2020-02-28", "has_results": false, "last_update_posted_date": "2020-07-08", "last_synced_at": "2026-07-24T09:46:00.729Z", "location_count": 1, "location_summary": "Temple, Texas", "locations": [ { "city": "Temple", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03384043" } ] }